Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-40.85	35.98	60.83
Graham Fair Price	57.77	8.28	5.25
PEG	12.23	0.05	0.04
Price/Book	6.00	1.37	1.30
Price/Cash Flow	-492.14	-78.22	-13.21
Prices/Earnings	-52.82	6.97	14.77
Price/Sales	7.43	10.34	9.63
Price/FCF	-492.14	-78.22	-13.21
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	34.01	0.54	0.40
Operating Margin	213.48	0.41	0.13
ROA	131.33	0.02	< 0.005
ROE	0.02	0.05	124.70
ROIC	< 0.005	0.02	254.29
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.03	0.11	-77.21
Dividends QOQ	0.30	-0.11	-62.09
EBIT QOQ	3.42	2.26	-34.00
EPS QOQ	3.42	1.44	-57.97
FCF QOQ	0.49	0.81	65.09
Revenue QOQ	0.38	0.04	-89.79
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	15.16	19.11	26.05
Days Sales Outstanding (DSO)	170.47	164.53	-3.48
Inventory Turnover	5.94	4.71	-20.67
Debt/Capitalization	0.52	0.52	-1.22
Quick Ratio	1.46	1.62	11.10
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	7.47	7.86	5.25
Cash	2.65	2.65	-0.01
Capex	-1.13	-0.48	57.78
Free Cash Flow	-0.73	-0.14	81.16
Revenue	1.01	1.04	3.85
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.51	1.73	14.60
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	22.07	12.47	-43.52
Naive Interpretation	Member

06 - Financial Health · Weak

Rating